Esperion Therapeutics, Inc.

ESPRDelisted Jul 13, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001434868

SEC filings (opens in a new tab)

Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.

Q2 2025 vs. Q1 2025

How the institutions holding Esperion Therapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025 All holders in Q1 2025

13F holders of ESPR: Q1 2025 compared with Q2 2025
Measure	Q1 2025	Of which not filed for Q2 2025	Q2 2025	Change
Holders	187	1	164	−22
Shares	113.6M	23.1K	98.2M	−15.4M (−13.5%)
Value	$171.5M	$40.0K	$96.6M	−$74.8M (−43.6%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (14)

Institutions that held Esperion Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to ESPR in Q2 2025
Institution	Shares	Value	% of portfolio
Renaissance Technologies LLC	292,400	$287.8K	0.00%
UBS Asset Management Americas Inc	249,500	$245.5K	0.00%
Umb Bank N A	170,000	$167.3K	0.00%
Sivia Capital Partners, LLC	25,738	$25.3K	0.01%
North Star Investment Management Corp.	25,000	$24.6K	0.00%
Wealth Enhancement Advisory Services, LLC	15,522	$18.2K	0.00%
Alpine Global Management, LLC	17,731	$17.5K	0.00%
Avantax Advisory Services, Inc.	12,877	$12.7K	0.00%
Ieq Capital, LLC	12,501	$12.3K	0.00%
Abel Hall, LLC	12,312	$12.1K	0.01%
Wolverine Trading, LLC	10,805	$10.7K	0.00%
Wealthcare Advisory Partners LLC	10,000	$9.84K	0.00%
Allworth Financial LP	1,000	$985	0.00%
Nisa Investment Advisors, LLC	941	$926	0.00%

Sold out (36)

Institutions that held Esperion Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of ESPR in Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Bellevue Group AG	9,694,064	$14.0M
Rhenman & Partners Asset Management AB	1,066,495	$1.54M
Connor, Clark & Lunn Investment Management Ltd.	822,618	$1.18M
Wellington Management Group LLP	761,980	$1.10M
HRT Financial LP	669,829	$964.0K
Graham Capital Management, L.P.	487,735	$702.3K
Marex Group plc	350,000	$504.0K
D. E. Shaw & Co., Inc.	275,707	$397.0K
Virtus Investment Advisers, Inc.	140,800	$202.8K
Corebridge Financial, Inc.	92,571	$133.3K
Rangeley Capital, LLC	92,500	$133.2K
Aristeia Capital LLC	70,959	$102.2K
Profund Advisors LLC	51,113	$73.6K
Eaton Financial Holdings Company, LLC	49,530	$71.3K
Lazard Asset Management LLC	43,815	$63.0K
Rafferty Asset Management, LLC	40,608	$58.5K
Headlands Technologies LLC	38,447	$55.4K
Belpointe Asset Management LLC	38,000	$54.7K
Synergy Financial Management, LLC	31,000	$44.6K
Nomura Holdings Inc	23,578	$34.0K
Crawford Investment Counsel Inc	20,000	$28.8K
Meridian Wealth Management, LLC	20,000	$28.8K
Sanders Morris Harris LLC	20,073	$28.6K
Engineers Gate Manager LP	19,131	$27.5K
CI Private Wealth, LLC	15,000	$21.6K
Farringdon Capital, Ltd.	13,514	$19.5K
Sigma Planning Corp	12,250	$17.6K
SIH Partners, LLLP	11,411	$16.4K
Stonepine Capital Management, LLC	10,000	$14.4K
Anchor Investment Management, LLC	3,000	$4.32K
Laurel Wealth Advisors LLC	2,500	$3.60K
Massmutual Trust Co FSB	1,394	$2.01K
The PNC Financial Services Group, Inc.	1,297	$1.87K
Coldstream Capital Management Inc	550	$792
Clear Street Markets LLC	412	$593
True Wealth Design, LLC	22	$32

Not filed for Q2 2025 yet (1)

Institutions that held Esperion Therapeutics, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ESPR in Q1 2025 that haven't filed for Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Delta Financial Group, Inc.	23,150	$40.0K